WebSify
Follow us on
Mail
Print

Recent Market Activity in Taro's Common Stock

Source : BUSINESS_WIRE
Last Updated: Fri, Apr 06, 2012 12:00 hrs

Hawthorne, New York, United States:

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro,” or the “Company”), today announced that in view of the unusual market activity in the Company’s stock, the New York Stock Exchange (“NYSE”) has contacted the Company in accordance with its usual practice. The NYSE has asked the Company to respond by press release to the unusual activity.

The Company’s policy is not to comment on unusual market activity, rumors or speculation.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

SAFE HARBOR STATEMENTS

Certain statements in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements that do not describe historical facts and statements that refer or relate to events or circumstances Taro “estimates,” “believes,” or “expects” to happen or similar language. The forward-looking statements in this press release are based on Taro’s current expectations and are made only as of the date of this press release and involve certain risks and uncertainties that could cause actual results to differ materially from future results that may be expressed or implied by such forward-looking statements. Unless required by law, Taro undertakes no obligations to update, change or revise any forward-looking statement, whether as a result of new information, additional or subsequent developments or otherwise.


Contact:
CONTACTS : Taro William J. Coote, 914-345-9001 VP, Treasurer William.Coote@taro.com , ,

blog comments powered by Disqus
most popular on facebook
talking point on sify finance